1. Home
  2. AMBA vs AUPH Comparison

AMBA vs AUPH Comparison

Compare AMBA & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$90.77

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.55

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
AUPH
Founded
2004
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
AMBA
AUPH
Price
$90.77
$15.55
Analyst Decision
Strong Buy
Buy
Analyst Count
9
4
Target Price
$97.25
$17.25
AVG Volume (30 Days)
839.0K
1.1M
Earning Date
05-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
37.32
5075.00
EPS
N/A
0.25
Revenue
$295,402,000.00
$283,055,000.00
Revenue This Year
$15.03
$17.54
Revenue Next Year
$12.41
$15.74
P/E Ratio
N/A
$60.78
Revenue Growth
N/A
20.38
52 Week Low
$48.30
$7.29
52 Week High
$96.69
$16.88

Technical Indicators

Market Signals
Indicator
AMBA
AUPH
Relative Strength Index (RSI) 73.35 49.57
Support Level $71.00 $14.53
Resistance Level $96.69 $16.38
Average True Range (ATR) 4.70 0.67
MACD 0.83 -0.06
Stochastic Oscillator 75.53 60.64

Price Performance

Historical Comparison
AMBA
AUPH

About AMBA Ambarella Inc.

Ambarella Inc is a developer of low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. Its products are used in a wide variety of human viewing, computer vision for edge and physical AI applications, including a variety of video security cameras, automotive camera systems, fixed robots, autonomous mobile robots (AMRs), industrial applications, intelligent transportation systems, and consumer devices, such as action, drone and 360 degree cameras. The company operates as a single operating and reportable segment and derives substantially all of its revenue from development and sales of low-power AI-based processing and video and image processing SoC solutions.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: